Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05065385

The EveryPrem Project: Evaluating the INTER-NDA for Standardized Neurodevelopmental Screening at 2 Years of Age for Children Born Preterm.

Sponsor: Giancarlo Natalucci

View on ClinicalTrials.gov

Summary

Neurodevelopmental follow-up of infants at high-risk such as preterm born is necessary in order to early detect impairments and early start a supportive/therapeutic intervention. Valid tools should be available for screening infants with developmental problems even where resources are limited. Such screening would ensure an adequate medical care during and after hospital discharge as well as evidence-based parental pre- and postnatal counselling. While in Switzerland, these tools are specifically needed for the neurodevelopmental surveillance of moderate to late pretem born infants, in low- and mid-income countries, they are needed to monitor the whole population of preterm born infants. To fill this important gap, the present study aims to determine whether it is feasible to extend neurodevelopmental screening (currently offered to only a very small part of children born preterm), by using a new cost-effective neurodevelopmental assessment, the INTERGROWTH-21st Neurodevelopment Assessment (INTER-NDA, www.inter-nda.com Assessment) at age 2 years.

Key Details

Gender

All

Age Range

18 Months - 30 Months

Study Type

OBSERVATIONAL

Enrollment

800

Start Date

2022-03-01

Completion Date

2026-12-31

Last Updated

2026-04-14

Healthy Volunteers

Yes

Conditions

Interventions

DIAGNOSTIC_TEST

INTER-NDA

Neurodevelopmental Screening Test at age 2 years.

Locations (1)

Department of Neonatology

Zurich, Canton of Zurich, Switzerland